Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
The current Cytokinetics(CYTK) stock price is $64.60, with a market capitalization of 7.89B. The stock trades at a price-to-earnings (P/E) ratio of -10.04.
On 2026-01-14, Cytokinetics(CYTK) stock traded between a low of $62.17 and a high of $65.08. Shares are currently priced at $64.60, which is +3.9% above the low and -0.7% below the high.
Cytokinetics(CYTK) shares are trading with a volume of 1.61M, against a daily average of 2.1M.
In the last year, Cytokinetics(CYTK) shares hit a 52-week high of $70.98 and a 52-week low of $29.31.
In the last year, Cytokinetics(CYTK) shares hit a 52-week high of $70.98 and a 52-week low of $29.31.
CYTK News
Allegations around Cytokinetics (CYTK) and its handling of FDA communications on aficamten have pushed governance and disclosure risks to the forefront, giving...
Cytokinetics recently faced a shareholder rights investigation by Grabar Law Office over allegations that it made misleading statements about the FDA’s review o...